Use of a Pulmonary Artery Pressure Sensor to Manage Patients With Left Ventricular Assist Devices.

"Disclosures Dr Thohan is a consultant for Abbott, Impulse Dynamics, and Battelle and participated in Speaker’s Bureau for Pfizer and Boehringer Ingelheim. Dr Abraham is a consultant for Abbott and Abiomed. A. Burdorf participated in Speaker’s Bureau for Abbott. Dr Pagani works for Scientific Advisory Board for FineHeart Inc. Dr Vidula received research grant funding from Abbott and is supported by National Institutes of Health (NIH) grant 1R01HL155201-01. Dr Heywood received Speaker’s Honoraria and research support from Abbott. Dr Cogswell received Speaker’s Honoraria for Abbott. He is third party employed at Medtronic (spouse). N. Dirckx and Dr Farrar are Abbott Employees. Dr Drakos is a consultant for Abbott. He received research support from Novartis, Merck, NIH, American Heart Association, Department of Veterans Affairs, and Nora Eccles Treadwell Foundation. The other authors report no conflicts."

"Sources of Funding The INTELLECT 2-HF study (Investigation to Optimize Hemodynamic Management of HeartMate II Left Ventricular Assist Device Patients Using the CardioMEMS Pulmonary Artery Pressure Sensor in Advanced Heart Failure) was funded by Abbott."

"Registration:: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03247829."